Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Completed Initiated Feb 18, 2025 (2 years ago)

Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: due to a quality control process deviation

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.

Affected NDC 83556-0101-01

Compare with the code on your package — it is the most precise check available.

Recalling firm
Turbare Manufacturing
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0248-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now completed, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other sterility / contamination recalls from 2025

All sterility / contamination recalls
Class II · Moderate risk

Vista Gonio Eye Lubricant

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Ongoing Sterility / contamination Wizcure Pharmaa Private Limited NDC 77790-022-15 D-0349-2026